Cargando…
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
AIMS: To examine the short- and long-term cost-effectiveness of intensive multifactorial treatment compared with routine care among people with screen-detected Type 2 diabetes. METHODS: Cost–utility analysis in ADDITION-UK, a cluster-randomized controlled trial of early intensive treatment in people...
Autores principales: | Tao, L, Wilson, E C F, Wareham, N J, Sandbæk, A, Rutten, G E H M, Lauritzen, T, Khunti, K, Davies, M J, Borch-Johnsen, K, Griffin, S J, Simmons, R K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510785/ https://www.ncbi.nlm.nih.gov/pubmed/25661661 http://dx.doi.org/10.1111/dme.12711 |
Ejemplares similares
-
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial
por: Black, J A, et al.
Publicado: (2014) -
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
por: Simmons, R K, et al.
Publicado: (2012) -
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial
por: Griffin, Simon J, et al.
Publicado: (2011) -
Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial
por: Van den Donk, Maureen, et al.
Publicado: (2013) -
Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study
por: Sandbaek, A., et al.
Publicado: (2008)